CASI Pharmaceuticals (CASIF) Return on Assets [ROA] (2023 - 2025)
CASI Pharmaceuticals (CASIF) recorded Return on Assets [ROA] of -475.40% in Q4 2025, down 408.46 percentage points from -66.94% a year earlier and down 297.17 percentage points from the prior quarter.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Return on Assets [ROA] (2023 - 2025) Analysis & Trends
For FY2025, CASI Pharmaceuticals reported Return on Assets [ROA] of -121.27%, down 60.38 percentage points from FY2024.
- Annual Return on Assets [ROA] has a three-year change of -86.95 percentage points (FY2022 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at -60.89% in FY2024 (-30.27 pp), -30.62% in FY2023 (+3.71 pp) and -34.33% in FY2022.
- The Q4 2025 figure is the lowest quarterly Return on Assets [ROA] in data going back to Q1 2023.
- On a year-over-year basis, Return on Assets [ROA] has declined for six consecutive quarters, with an average year-over-year change of -87.74 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 0.93 percentage points in Q2 2024, against a drop of 408.46 percentage points in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -178.24% (Q3 2025), -130.89% (Q2 2025) and -86.84% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | CASI Pharmaceuticals | 2.06 Mn | -18.77 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -191.94% |
| Sep 30, 2025 | -178.24% |
| Jun 30, 2025 | -130.89% |
| Mar 31, 2025 | -86.84% |
| Dec 31, 2024 | -66.94% |
| Sep 30, 2024 | -50.31% |
| Jun 30, 2024 | -45.92% |
| Mar 31, 2024 | -45.11% |
| Dec 31, 2023 | -35.13% |
| Sep 30, 2023 | -46.60% |
| Jun 30, 2023 | -46.85% |
| Mar 31, 2023 | -40.88% |
API Access
CASI Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();